肺癌是全球发病率第二、死亡率第一的恶性肿瘤,近年来随着基因检测技术及新药的广泛应用,肺癌的死亡率虽有所下降,但其预后仍较差。研究表明,肺癌是一种典型的炎症及代谢相关性疾病,本文就近年来肺癌中常见的炎性蛋白复合指标的研究进展作一系统综述。
Lung cancer is the malignant tumor with the second morbidity and the first mortality rate in the world. In recent years, with the wide application of genetic testing technology and new drugs, the mortality rate of lung cancer has decreased, but its prognosis is still poor. The study shows that lung cancer is a typical inflammatory and metabolic related disease. This paper systematically summa-rizes the research progress of the common inflammatory protein composite index in lung cancer.
炎性指标,炎性相关蛋白,肺癌,预后, Inflammatory Indicators Inflammatory-Related Proteins Lung Cancer Prognosis摘要
Lung cancer is the malignant tumor with the second morbidity and the first mortality rate in the world. In recent years, with the wide application of genetic testing technology and new drugs, the mortality rate of lung cancer has decreased, but its prognosis is still poor. The study shows that lung cancer is a typical inflammatory and metabolic related disease. This paper systematically summarizes the research progress of the common inflammatory protein composite index in lung cancer.
轩晓倩,赵君慧. 炎性蛋白复合指标在肺癌预后中的研究进展Research Progress of Inflammatory Protein Composite Index in the Prognosis of Lung Cancer[J]. 临床医学进展, 2022, 12(06): 5727-5731. https://doi.org/10.12677/ACM.2022.126827
参考文献ReferencesSung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
<br>https://doi.org/10.3322/caac.21660Allemani, C., et al. (2018) Global Surveillance of Trends in Cancer Sur-vival 2000-14 (CONCORD-3): Analysis of Individual Records for 37513025 Patients Diagnosed with One of 18 Can-cers from 322 Population-Based Registries in 71 Countries. The Lancet, 391, 1023-1075.Yamamoto, M., Saito, H., Uejima, C., et al. (2018) Prognostic Value of the Combination of Pre- and Post-Operative C-Reactive Protein in Colorec-tal Cancer Patients. Surgery Today, 48, 986-993.
<br>https://doi.org/10.1007/s00595-018-1689-9Matsubara, T., et al. (2020) Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer. Surgical Oncology, 28, 3046-3054.
<br>https://doi.org/10.1245/s10434-020-09230-xAkamine, T., Takada, K., Toyokawa, G., et al. (2018) Associa-tion of Preoperative Serum CRP with PD-L1 Expression in 508 Patients with Non-Small Cell Lung Cancer: A Compre-hensive Analysis of Systemic Inflammatory Markers. Surgical Oncology, 27, 88-94. <br>https://doi.org/10.1016/j.suronc.2018.01.002郑勇, 闫颖伟, 杨保参, 等. 非小细胞肺癌患者术前肿瘤标志物和CRP表达水平与预后的相关性[J]. 中国卫生工程学, 2021, 20(6): 975-977. <br>https://doi.org/10.19937/j.issn.1671-4199.2021.06.034刘红. C反应蛋白及纤维蛋白原在肺癌患者中的临床意义[J]. 中国医药指南, 2019, 17(31): 6-7.
<br>https://doi.org/10.15912/j.cnki.gocm.2019.31.004Schuetz, P., Fehr, R., Baechli, V., et al. (2019) Individual-ised Nutritional Support in Medical Inpatients at Nutritional risk: A Randomised Clinical Trial. The Lancet, 393, 2312-2321. <br>https://doi.org/10.1016/S0140-6736(18)32776-4石汉平. 肿瘤是一种代谢性疾病[J]. 肿瘤代谢与营养电子杂志, 2018, 5(2): 111-116.Song, J., Li, Y., Deng, A.B., et al. (2021) Value of NLR, Alb and T-Lymphocyte Subsets CD4+ on the Prognostic Assessment of Patients with Middle and Advanced Lung Cancer Un-derwent Radiofrequency Ablation. China Medical Equipment, 18, 73-77.Chen, Z., Shao, Y., Fan, M., et al. (2015) Prognostic Significance of Preoperative C-Reactive Protein: Albumin Ratio in Patients with Clear Cell Renal Cell Carci-noma. International Journal of Clinical and Experimental Pathology, 8, 14893-900.周倩. 晚期非小细胞肺癌维持治疗的研究进展[J]. 中国肿瘤临床, 2021, 48(12): 631-635.李亚伦, 李镭, 张立, 等. 血清白蛋白及尿素氮水平与肺癌不同临床病理特征和预后的关系[J]. 中国肺癌杂志, 2017, 20(3): 175-186.宋健, 李杨, 邓爱兵, 等. 中性粒细胞与淋巴细胞比值、白蛋白及T淋巴细胞亚群CD4~+对中晚期肺癌射频消融术预后评估的意义[J]. 中国医学装备, 2021, 18(2): 73-77.王兴盛, 田振伟, 储洪博, 等. 非小细胞肺癌患者化疗前后的 C反应蛋白和血清白蛋白水平变化[J]. 中国现代医学杂志, 2013, 23(24): 46-49.嵇桂娟, 刘平莉, 罗涛, 等. 初始治疗前CRP/Alb比值与小细胞肺癌患者临床病理特征及预后的关系[J]. 徐州医科大学学报, 2019, 39(7): 481-486.张晓娇, 张毛为, 朱洁晨, 等. 非小细胞肺癌患者围手术期CRP/Alb数值对临床分期及预后的诊断价值研究[J]. 中国校医, 2019, 33(10): 772-774+789.Zhu, L., Chen, S., Ma, S., et al. (2016) Glasgow Prog-nostic Score Predicts Prognosis of Non-Small Cell Lung Cancer: A Meta-Analysis. SpringerPlus, 5, 439. <br>https://doi.org/10.1186/s40064-016-2093-9Kurishima, K., Watanabe, H., Ishikawa, H., et al. (2017) Modified Glasgow Prognostic Score in Patients with Small-Cell Lung Cancer. Molecular and Clinical Oncology, 7, 121-124. <br>https://doi.org/10.3892/mco.2017.1261王文波, 侯智亮, 徐文举, 等. 改良Glasgow预后评分对非小细胞肺癌胸腔镜肺叶切除术后的预后价值[J]. 实用肿瘤杂志, 2020, 35(1): 88-97.孙海双. 血清白蛋白水平与非小细胞肺癌患者机体免疫状态及预后的相关性分析[D]: [硕士学位论文]. 长春: 吉林大学, 2020.代焕, 朱正秋, 陈嘉劼. 系统免疫炎症指数、预后营养指数对III~IV期非小细胞肺癌一线化疗患者预后的预测价值[J]. 医学研究杂志, 2022, 51(3): 121-126.蒋爱民, 任梦迪, 马宇彦, 等. 预后营养指数作为非小细胞肺癌预后因素的Meta分析[J]. 现代肿瘤医学, 2022, 30(8): 1406-1411.张立明, 宋文鹏, 王彦, 等. 治疗前预后营养指数与小细胞肺癌患者预后相关性的meta分析[J]. 华西医学, 2022, 37(3): 424-430.Jafri, S.H., Shi, R. and Mills, G. (2013) Advance Lung Cancer Inflammation Index (ALI) at Diagnosis Is a Prognostic Marker in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC): A Retrospective Review. BMC Cancer, 13, Article No. 158. <br>https://doi.org/10.1186/1471-2407-13-158Li, S.M., Zhang, C.Y., Pang, G.C., et al. (2020) Emerging Blood-Based Biomarkers for Predicting Response to Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer. Fron-tiers in Immunology, 11, ID: 603157.
<br>https://doi.org/10.3389/fimmu.2020.603157Wang, Y., Lin, L., Ji, Y., et al. (2020) Prognostic Value of the Advanced Lung Cancer Inflammation Index in Early-Stage Non-Small Cell Lung Cancer Patients Undergoing Vid-eo-Assisted Thoracoscopic Pulmonary Resection. Annals of Palliative Medicine, 9, 721-729. <br>https://doi.org/10.21037/apm.2020.03.18